Patent · US Expired

Viral vectors and line for gene therapy

US6204060A · kind A · utility

40Cited by

0References

42Claims

0Family size

Assignee

TRANSGENE SA · FR

Inventors

Majid Mehtali · Strasbourg, FR
Monika Lusky · Glückstadt, DE
Karola Rittner · Strasbourg, FR

Key dates

Filing date	Mar 31, 1997
Grant date	Mar 20, 2001
Priority date	—
Expiry date	Mar 31, 2017

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel viral vectors in which the expression of viral genes is regulated in such a way that it is functional in a complementation cell and non-functional in a host cell, as well as viral particles and host cells containing said novel vectors, are disclosed. A complementation cell including a viral gene expression regulator, and a method for preparing infectious viral particles, are also disclosed. Finally, a pharmaceutical composition containing said vectors, and the therapeutical use thereof, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.